The efficacy and safety of levatinib, folfox4-haic combined with tislelizumab in the treatment of intermediate advanced hepatocellular carcinoma: A singe-center, single-arm, prospective real-world study

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2022
This article has no abstract
Epistemonikos ID: ff498e3424c655ab2b365ef8b52583a0c1b43566
First added on: Apr 08, 2025